NASDAQ · Biotechnology

Allogene Therapeutics Inc (ALLO)

$1.18 -5.60%
Add alert See all oversold stocks →
29 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$1.99-40.70%

Company profile

Allogene Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and markets genetically engineered allogeneic T-cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California.

SectorHealthcare
IndustryBiotechnology
Market cap$483.69M
P/E ratioNone
EPS$-0.66
Beta0.559
Dividend yield0.00%
52-week high$4.46
52-week low$1.04

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 ALT Altimmune Inc RSI 27 CAPR Capricor Therapeutics Inc RSI 42 EDIT Editas Medicine Inc RSI 51 ARCT Arcturus Therapeutics Holdings Inc RSI 45 AGEN Agenus Inc RSI 47 ARTV Artiva Biotherapeutics Inc RSI 21
30 days of PRO Unlimited free, no card

RSI alerts for ALLO

An email when ALLO closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 10:30 PM EDT